Mouse Cnot1 Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Cnot1 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Cnot1 Knockout Project (CRISPR/Cas9) Objective: To create a Cnot1 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cnot1 gene (NCBI Reference Sequence: NM_001205226 ; Ensembl: ENSMUSG00000036550 ) is located on Mouse chromosome 8. 49 exons are identified, with the ATG start codon in exon 2 and the TAG stop codon in exon 49 (Transcript: ENSMUST00000211887). Exon 5~12 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice hmozygous for a conditional allele activated in cardiomyocytes exhibit postnatal lethality, decreased cardiac muscle contractility, prolonged QT interval and cardiac muscle cell death. Exon 5 starts from about 4.28% of the coding region. Exon 5~12 covers 14.55% of the coding region. The size of effective KO region: ~9183 bp. The KO region does not have any other known gene. Page 1 of 10 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 5 6 7 8 9 10 11 12 49 Legends Exon of mouse Cnot1 Knockout region Page 2 of 10 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 990 bp section upstream of Exon 5 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 1226 bp section downstream of Exon 12 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 10 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(990bp) | A(27.07% 268) | C(17.88% 177) | T(34.95% 346) | G(20.1% 199) Note: The 990 bp section upstream of Exon 5 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(1226bp) | A(30.18% 370) | C(14.93% 183) | T(38.01% 466) | G(16.88% 207) Note: The 1226 bp section downstream of Exon 12 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 10 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 990 1 990 990 100.0% chr8 - 95773640 95774629 990 browser details YourSeq 276 466 949 990 94.9% chr4 + 122993520 122994099 580 browser details YourSeq 272 328 952 990 92.6% chr2 + 121607825 121608472 648 browser details YourSeq 256 459 964 990 87.5% chr13 + 98806477 98806818 342 browser details YourSeq 251 475 944 990 93.5% chr1 + 13087406 13088042 637 browser details YourSeq 228 506 949 990 92.3% chr15 + 38111462 38112107 646 browser details YourSeq 222 476 950 990 87.0% chr11 + 100475501 100475842 342 browser details YourSeq 211 466 940 990 84.6% chr11 + 97724675 97725065 391 browser details YourSeq 208 500 940 990 93.4% chr19 - 32334394 32734713 400320 browser details YourSeq 202 462 975 990 87.2% chr1 + 183326221 183326640 420 browser details YourSeq 199 482 919 990 85.4% chr7 + 4818717 4818994 278 browser details YourSeq 187 744 961 990 91.4% chr8 + 80843352 80843560 209 browser details YourSeq 183 767 953 990 99.0% chr4 - 32575709 32575895 187 browser details YourSeq 179 770 957 990 97.9% chr18 - 38173391 38173579 189 browser details YourSeq 177 749 951 990 97.4% chr11 + 70902584 70902786 203 browser details YourSeq 176 556 950 990 93.6% chr14 - 60725227 60725648 422 browser details YourSeq 176 767 952 990 97.4% chr10 - 80860264 80860449 186 browser details YourSeq 174 749 957 990 90.1% chr7 + 52755896 52756097 202 browser details YourSeq 174 768 951 990 97.3% chr1 + 170185742 170185925 184 browser details YourSeq 173 769 952 990 96.7% chr5 - 115351236 115351418 183 Note: The 990 bp section upstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 1226 1 1226 1226 100.0% chr8 - 95763231 95764456 1226 browser details YourSeq 93 74 235 1226 80.5% chr12 - 6555285 6555444 160 browser details YourSeq 89 69 208 1226 83.6% chr1 - 42993913 43277189 283277 browser details YourSeq 87 21 175 1226 91.6% chr4 - 116067992 116068227 236 browser details YourSeq 87 74 215 1226 82.8% chr15 + 79225965 79226108 144 browser details YourSeq 73 66 175 1226 84.2% chr16 - 4174383 4174502 120 browser details YourSeq 72 64 168 1226 83.0% chr2 + 171631822 171631915 94 browser details YourSeq 69 68 155 1226 89.8% chr12 + 69190633 69190721 89 browser details YourSeq 66 74 155 1226 91.5% chrX - 88771528 88771612 85 browser details YourSeq 66 74 155 1226 91.5% chr2 - 126457943 126458027 85 browser details YourSeq 66 85 175 1226 86.7% chr19 + 43852982 43853073 92 browser details YourSeq 65 62 168 1226 87.4% chr1 - 75354573 75354677 105 browser details YourSeq 62 104 193 1226 84.5% chr2 - 164506081 164506170 90 browser details YourSeq 62 74 175 1226 83.7% chr14 - 47553559 47553672 114 browser details YourSeq 61 54 142 1226 89.8% chr13 + 38002558 38002653 96 browser details YourSeq 60 100 175 1226 89.5% chr1 + 20762424 20762499 76 browser details YourSeq 59 69 151 1226 85.8% chr9 + 21319609 21319689 81 browser details YourSeq 58 69 163 1226 81.3% chrX - 151354578 151354669 92 browser details YourSeq 58 74 155 1226 86.6% chrX + 94185257 94185341 85 browser details YourSeq 58 74 162 1226 92.8% chr9 + 124474981 124475072 92 Note: The 1226 bp section downstream of Exon 12 is BLAT searched against the genome. No significant similarity is found. Page 5 of 10 https://www.alphaknockout.com Gene and protein information: Cnot1 CCR4-NOT transcription complex, subunit 1 [ Mus musculus (house mouse) ] Gene ID: 234594, updated on 24-Oct-2019 Gene summary Official Symbol Cnot1 provided by MGI Official Full Name CCR4-NOT transcription complex, subunit 1 provided by MGI Primary source MGI:MGI:2442402 See related Ensembl:ENSMUSG00000036550 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as AA815922; D830048B13; 6030411K04Rik Expression Ubiquitous expression in testis adult (RPKM 29.9), placenta adult (RPKM 21.5) and 28 other tissues See more Orthologs human all Genomic context Location: 8; 8 D1 See Cnot1 in Genome Data Viewer Exon count: 49 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 8 NC_000074.6 (95719451..95808113, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 8 NC_000074.5 (98243351..98331366, complement) Chromosome 8 - NC_000074.6 Page 6 of 10 https://www.alphaknockout.com Transcript information: This gene has 17 transcripts Gene: Cnot1 ENSMUSG00000036550 Description CCR4-NOT transcription complex, subunit 1 [Source:MGI Symbol;Acc:MGI:2442402] Gene Synonyms 6030411K04Rik Location Chromosome 8: 95,719,451-95,807,464 reverse strand. GRCm38:CM001001.2 About this gene This gene has 17 transcripts (splice variants), 212 orthologues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Cnot1- ENSMUST00000211887.1 8364 2369aa ENSMUSP00000148807.1 Protein coding CCDS85589 A0A1D5RMJ8 TSL:1 203 GENCODE basic APPRIS P2 Cnot1- ENSMUST00000068452.9 8152 2326aa ENSMUSP00000063565.8 Protein coding CCDS57635 B7ZWL1 TSL:1 201 GENCODE basic Cnot1- ENSMUST00000098473.10 8390 2376aa ENSMUSP00000096073.4 Protein coding - Q6ZQ08 TSL:5 202 GENCODE basic APPRIS ALT1 Cnot1- ENSMUST00000211973.1 2469 823aa ENSMUSP00000148831.1 Protein coding - A0A1D5RML9 CDS 5' and 3' 205 incomplete TSL:5 Cnot1- ENSMUST00000213046.1 550 92aa ENSMUSP00000148709.1 Protein coding - A0A1D5RMB6 CDS 3' 217 incomplete TSL:3 Cnot1- ENSMUST00000213006.1 7479 1614aa ENSMUSP00000148735.1 Nonsense mediated - A0A1D5RMD8 TSL:1 216 decay Cnot1- ENSMUST00000212323.1 3277 213aa ENSMUSP00000148574.1 Nonsense mediated - A0A1D5RM03 TSL:2 209 decay Cnot1- ENSMUST00000212415.1 956 122aa ENSMUSP00000148575.1 Nonsense mediated - A0A1D5RM04 CDS 5' 212 decay incomplete TSL:5 Cnot1- ENSMUST00000212302.1 3809 No - Retained intron - - TSL:1 208 protein Cnot1- ENSMUST00000212228.1 2925 No - Retained intron - - TSL:1 207 protein Cnot1- ENSMUST00000212340.1 2381 No - Retained intron - - TSL:NA 210 protein Cnot1- ENSMUST00000212195.1 696 No - Retained intron - - TSL:3 206 protein Cnot1- ENSMUST00000212712.1 656 No - Retained intron - - TSL:3 215 protein Cnot1- ENSMUST00000211937.1 500 No - Retained intron - - TSL:3 204 protein Cnot1- ENSMUST00000212369.1 479 No - Retained intron - - TSL:2 211 protein Cnot1- ENSMUST00000212535.1 1546 No - lncRNA
Recommended publications
  • Analysis of Trans Esnps Infers Regulatory Network Architecture
    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Dissertation
    Regulation of gene silencing: From microRNA biogenesis to post-translational modifications of TNRC6 complexes DISSERTATION zur Erlangung des DOKTORGRADES DER NATURWISSENSCHAFTEN (Dr. rer. nat.) der Fakultät Biologie und Vorklinische Medizin der Universität Regensburg vorgelegt von Johannes Danner aus Eggenfelden im Jahr 2017 Das Promotionsgesuch wurde eingereicht am: 12.09.2017 Die Arbeit wurde angeleitet von: Prof. Dr. Gunter Meister Johannes Danner Summary ‘From microRNA biogenesis to post-translational modifications of TNRC6 complexes’ summarizes the two main projects, beginning with the influence of specific RNA binding proteins on miRNA biogenesis processes. The fate of the mature miRNA is determined by the incorporation into Argonaute proteins followed by a complex formation with TNRC6 proteins as core molecules of gene silencing complexes. miRNAs are transcribed as stem-loop structured primary transcripts (pri-miRNA) by Pol II. The further nuclear processing is carried out by the microprocessor complex containing the RNase III enzyme Drosha, which cleaves the pri-miRNA to precursor-miRNA (pre-miRNA). After Exportin-5 mediated transport of the pre-miRNA to the cytoplasm, the RNase III enzyme Dicer cleaves off the terminal loop resulting in a 21-24 nt long double-stranded RNA. One of the strands is incorporated in the RNA-induced silencing complex (RISC), where it directly interacts with a member of the Argonaute protein family. The miRNA guides the mature RISC complex to partially complementary target sites on mRNAs leading to gene silencing. During this process TNRC6 proteins interact with Argonaute and recruit additional factors to mediate translational repression and target mRNA destabilization through deadenylation and decapping leading to mRNA decay.
    [Show full text]
  • Importance of the Conserved Carboxyl-Terminal CNOT1 Binding Domain to Tristetraprolin Activity in Vivo Wi S
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2019 Importance of the conserved carboxyl-terminal CNOT1 binding domain to tristetraprolin activity in vivo Wi S. Lai Deborah J. Stumpo Melissa L. Wells Artion Gruzdev Stephanie N. Hicks See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Authors Wi S. Lai, Deborah J. Stumpo, Melissa L. Wells, Artion Gruzdev, Stephanie N. Hicks, Cindo O. Nicholson, Zhengfeng Yang, Roberta Faccio, Michael W. Webster, Lori A. Passmore, and Perry J. Blackshear RESEARCH ARTICLE crossm Importance of the Conserved Carboxyl-Terminal CNOT1 Binding Domain to Tristetraprolin Activity In Vivo Wi S. Lai,a Deborah J. Stumpo,a Melissa L. Wells,a Artiom Gruzdev,b Stephanie N. Hicks,a Cindo O. Nicholson,a Zhengfeng Yang,c,f* Roberta Faccio,c,f Michael W. Webster,d* Lori A. Passmore,d Perry J. Blacksheara,e Downloaded from aSignal Transduction Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA bReproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA cDepartment of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA dMRC Laboratory of Molecular Biology, Cambridge, United Kingdom eDepartments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina, USA fShriners Hospitals for Children, St. Louis, Missouri, USA ABSTRACT Tristetraprolin (TTP) is an anti-inflammatory protein that modulates the sta- http://mcb.asm.org/ bility of certain cytokine/chemokine mRNAs. After initial high-affinity binding to AU-rich elements in 3= untranslated regions of target mRNAs, mediated through its tandem zinc finger (TZF) domain, TTP promotes the deadenylation and ultimate decay of target tran- scripts.
    [Show full text]
  • Importance of CNOT8 Deadenylase Subunit in DNA Damage Responses Following Ionizing Radiation (IR)
    Reports of Biochemistry & Molecular Biology Vol.9, No.1, July 2020 Original article www.RBMB.net Importance of CNOT8 Deadenylase Subunit in DNA Damage Responses Following Ionizing Radiation (IR) Samira Eskandarian1,2, Roger Grand2, Shiva Irani*1, Mohsen Saeedi3, Reza Mirfakhraie4 Abstract Background: The Ccr4-Not protein complex (CNOT complex) is a key regulator of gene expression in eukaryotic cells. Ccr4-Not Complex is composed of at least nine conserved subunits in mammalian cells with two main enzymatic activities. CNOT8 is a subunit of the complex with deadenylase activity that interacts transiently with the CNOT6 or CNOT6L subunits. Here, we focused on the role of the human CNOT8 subunit in the DNA damage response (DDR). Methods: Cell viability was assessed to measure ATP level using a Cell Titer-Glo Luminescence reagent up to 4 days’ post CNOT8 siRNA transfection. In addition, expression level of phosphorylated proteins in signalling pathways were detected by western blotting and immunofluorescence microscopy. CNOT8- depleted Hela cells post- 3 Gy ionizing radiation (IR) treatment were considered as a control. Results: Our results from cell viability assays indicated a significant reduction at 72-hour post CNOT8 siRNA transfection (p= 0.04). Western blot analysis showed slightly alteration in the phosphorylation of DNA damage response (DDR) proteins in CNOT8-depleted HeLa cells following treatment with ionizing radiation (IR). Increased foci formation of H2AX, RPA, 53BP1, and RAD51 foci was observed after IR in CNOT8-depleted cells compared to the control cells. Conclusions: We conclude that CNOT8 deadenylase subunit is involved in the cellular response to DNA damage. Keywords: CNOT complex, CNOT8, DNA damage response, SiRNA.
    [Show full text]
  • Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype
    Published OnlineFirst November 29, 2016; DOI: 10.1158/0008-5472.CAN-16-1346 Cancer Tumor and Stem Cell Biology Research Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype Paloma Cejas1,2,3, Alessia Cavazza1,2, C.N. Yandava1, Victor Moreno3, David Horst4, Juan Moreno-Rubio3, Emilio Burgos5, Marta Mendiola3,5, Len Taing1, Ajay Goel6, Jaime Feliu3, and Ramesh A. Shivdasani1,2 Abstract Cancer cells exhibit dramatic alterations of chromatin organi- primarily to genes whose expression was affected by CNOT3 loss, zation at cis-regulatory elements, but the molecular basis, extent, and also at sites modulated in certain types of colorectal cancers. and impact of these alterations are still being unraveled. Here, we These target genes were implicated in ESC and cancer self-renewal identify extensive genome-wide modification of sites bearing the and fell into two distinct groups: those dependent on CNOT3 and active histone mark H3K4me2 in primary human colorectal MYC for optimal transcription and those repressed by CNOT3 cancers, as compared with corresponding benign precursor ade- binding and promoter hypermethylation. Silencing CNOT3 in nomas. Modification of certain colorectal cancer sites highlighted colorectal cancer cells resulted in replication arrest. In clinical þ the activity of the transcription factor CNOT3, which is known to specimens, early-stage tumors that included >5% CNOT3 cells control self-renewal of embryonic stem cells (ESC). In primary exhibited a correlation to worse clinical outcomes compared with colorectal cancer cells, we observed a scattered pattern of CNOT3 tumors with little to no CNOT3 expression. Together, our findings expression, as might be expected for a tumor-initiating cell mark- implicate CNOT3 in the coordination of colonic epithelial cell er.
    [Show full text]
  • Inhibition of Notch Signaling Attenuates Pituitary Adenoma Growth in Nude Mice
    26 1 Endocrine-Related Z-B Lautaro et al. Notch inhibition and pituitary 26:1 13–29 Cancer tumor growth RESEARCH Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice Lautaro Zubeldía-Brenner1, Catalina De Winne1, Sofía Perrone2, Santiago A Rodríguez-Seguí3,4, Christophe Willems5, Ana María Ornstein1, Isabel Lacau-Mengido1, Hugo Vankelecom5, Carolina Cristina2* and Damasia Becu-Villalobos1* 1Instituto de Biología y Medicina Experimental, IBYME-CONICET, Buenos Aires, Argentina 2Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires, CITNOBA (UNNOBA-CONICET), Universidad Nacional del Noroeste de la Provincia de Buenos Aires, Buenos Aires, Argentina 3Departamento de Fisiología y Biología Molecular y Celular, Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Buenos Aires, Argentina 4CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina 5Department of Development and Regeneration, Cluster Stem Cell and Developmental Biology, Unit of Stem Cell Research, KU Leuven (University of Leuven), Leuven, Belgium Correspondence should be addressed to D Becu-Villalobos: [email protected] *(C Cristina and D Becu-Villalobos contributed equally) Abstract Preclinical and clinical studies support that Notch signaling may play an important Key Words oncogenic role in cancer, but there is scarce information for pituitary tumors. f DAPT We therefore undertook a functional study to evaluate Notch participation in f pituitary pituitary adenoma growth. Tumors generated in Nude mice by subcutaneous GH3 f angiogenesis somatolactotrope cell injection were treated in vivo with DAPT, a γ-secretase inhibitor, f prolactin thus inactivating Notch signaling. This treatment led to pituitary tumor reduction, lower f GH prolactin and GH tumor content and a decrease in angiogenesis.
    [Show full text]
  • The CCR4–NOT Deadenylase Complex Maintains Adipocyte Identity
    The CCR4 NOT Deadenylase Complex Maintains Adipocyte Identity Author Akinori Takahashi, Shohei Takaoka, Shungo Kobori, Tomokazu Yamaguchi, Sara Ferwati, Keiji Kuba, Tadashi Yamamoto, Toru Suzuki journal or International Journal of Molecular Sciences publication title volume 20 number 21 page range 5274 year 2019-10-24 Publisher MDPI Rights (C) 2019 The Author(s). Author's flag publisher URL http://id.nii.ac.jp/1394/00001061/ doi: info:doi/10.3390/ijms20215274 Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/) International Journal of Molecular Sciences Article The CCR4–NOT Deadenylase Complex Maintains Adipocyte Identity 1, 1, 2 3 Akinori Takahashi y, Shohei Takaoka y, Shungo Kobori , Tomokazu Yamaguchi , Sara Ferwati 1, Keiji Kuba 3 , Tadashi Yamamoto 1,4,* and Toru Suzuki 4,* 1 Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan; [email protected] (A.T.); [email protected] (S.T.); [email protected] (S.F.) 2 Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan; [email protected] 3 Depatment of Biochemistry and Metabolic Science, Graduate School of Medicine, Akita University, Akita 010-8543, Japan; [email protected] (T.Y.); [email protected] (K.K.) 4 Laboratory for Immunogenetics, Center for Integrative Medical Sciences, RIKEN, Kanagawa 230-0045, Japan * Correspondence: [email protected] (T.Y.); toru.suzuki.ff@riken.jp (T.S.); Tel.: +81-45-503-7009 (T.S.); Fax: +81-45-503-9558 (T.S.) These authors contributed equally to this work.
    [Show full text]
  • Thesis Final
    UNIVERSITY OF CALIFORNIA SANTA CRUZ IMPROVING GENE ANNOTATION AND UNDERSTANDING OF MAMMALIAN EVOLUTION BY IDENTIFYING RETROCOPIES OF MRNA TRANSCRIPTS A dissertation submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOINFORMATICS By Robert D. Baertsch June 2010 The Dissertation of Robert D. Baertsch Is approved: ________________________________ Professor David Haussler, Chair ________________________________ W. James Kent ________________________________ Professor John Tamkun Table of Contents ABSTRACT ................................................................................................................................................V DEDICATION.........................................................................................................................................VII ACKNOWLEDGEMENTS.................................................................................................................VIII 1. BACKGROUND .....................................................................................................................................1 Introduction to Transposable Elements.............................................................................................2 Transposable elements.................................................................................................................................... 3 Types of non-retroviral retrotransposons .....................................................................................................
    [Show full text]
  • Differential Regulation of Mrna Fate by the Human Ccr4-Not Complex Is Driven by CDS Composition and Mrna Localisation
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.13.435226; this version posted July 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Differential regulation of mRNA fate by the human Ccr4-Not complex is driven by CDS composition and mRNA localisation S.L. Gillen, C.Giacomelli, K. Hodge, S. Zanivan, M. Bushell* & A. Wilczynska* * corresponding authors Abstract Background: Regulation of protein output at the level of translation allows for a rapid adaptation to dynamic changes to the cell’s requirements. This precise control of gene expression is achieved by complex and interlinked biochemical processes that modulate both the protein synthesis rate and stability of each individual mRNA. A major factor coordinating this regulation is the Ccr4-Not complex. Despite playing a role in most stages of the mRNA life cycle, no attempt has been made to take a global integrated view of how the Ccr4-Not complex affects gene expression. Results: This study has taken a comprehensive approach to investigate post-transcriptional regulation mediated by the Ccr4-Not complex assessing steady-state mRNA levels, ribosome position, mRNA stability and protein production transcriptome-wide. Depletion of the scaffold protein CNOT1 results in a global upregulation of mRNA stability and the preferential stabilisation of mRNAs enriched for G/C-ending codons. We also uncover that mRNAs targeted to the ER for their translation have reduced translational efficiency when CNOT1 is depleted, specifically downstream of the signal sequence cleavage site.
    [Show full text]
  • Integrative Framework for Identification of Key Cell Identity Genes Uncovers
    Integrative framework for identification of key cell PNAS PLUS identity genes uncovers determinants of ES cell identity and homeostasis Senthilkumar Cinghua,1, Sailu Yellaboinaa,b,c,1, Johannes M. Freudenberga,b, Swati Ghosha, Xiaofeng Zhengd, Andrew J. Oldfielda, Brad L. Lackfordd, Dmitri V. Zaykinb, Guang Hud,2, and Raja Jothia,b,2 aSystems Biology Section and dStem Cell Biology Section, Laboratory of Molecular Carcinogenesis, and bBiostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709; and cCR Rao Advanced Institute of Mathematics, Statistics, and Computer Science, Hyderabad, Andhra Pradesh 500 046, India Edited by Norbert Perrimon, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, and approved March 17, 2014 (received for review October 2, 2013) Identification of genes associated with specific biological pheno- (mESCs) for genes essential for the maintenance of ESC identity types is a fundamental step toward understanding the molecular resulted in only ∼8% overlap (8, 9), although many of the unique basis underlying development and pathogenesis. Although RNAi- hits in each screen were known or later validated to be real. The based high-throughput screens are routinely used for this task, lack of concordance suggest that these screens have not reached false discovery and sensitivity remain a challenge. Here we describe saturation (14) and that additional genes of importance remain a computational framework for systematic integration of published to be discovered. gene expression data to identify genes defining a phenotype of Motivated by the need for an alternative approach for iden- interest. We applied our approach to rank-order all genes based on tification of key cell identity genes, we developed a computa- their likelihood of determining ES cell (ESC) identity.
    [Show full text]